RxDoctor Payments Data

Hernani Valerio, MD

Family Medicine · Newport News, VANPI 1093932444

Payments from drug & device makers

$1,440in general payments, 2019–2025

Across 82 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$250
  • Astellas Pharma US Inc$124
  • Pfizer$111
  • GSK$110
  • Amarin Pharma, Inc.$107
  • Boehringer Ingelheim$103
  • plus $635 from 15 others

What the payments were for

  • Food & beverage$1,440100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,440 in reported general payments places this provider in the 70th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$216,107
Medicare patients
367
Services billed
5,581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide161$212,132
EliquisApixaban94$93,455
OzempicSemaglutide35$57,217
JanuviaSitagliptin Phosphate66$48,032
JardianceEmpagliflozin64$47,844
XareltoRivaroxaban35$37,824
MounjaroTirzepatide12$22,936
Lantus SolostarInsulin Glargine,hum.Rec.Anlog98$18,869
Spiriva RespimatTiotropium Bromide21$18,466
TradjentaLinagliptin20$16,992
FarxigaDapagliflozin Propanediol15$11,918
SymbicortBudesonide/Formoterol Fumarate20$11,279
LantusInsulin Glargine,hum.Rec.Anlog24$7,681
Novolog FlexpenInsulin Aspart21$5,987
Albuterol Sulfate HfaAlbuterol Sulfate181$5,742

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$72$235,068173 claims
PfizerEliquis$111$93,45594 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$103$83,302105 claims
Novo NordiskOzempic$71$57,21735 claims
MerckJanuvia, Dulera$28$51,94977 claims
Johnson & JohnsonXarelto$45$37,82435 claims
AstraZenecaFarxiga, Symbicort$74$23,19735 claims
Sanofi-aventis U.S. LLCLantus$33$7,68124 claims
AbbVieSynthroid$90$1,80720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →